The case of a child with severe hyperphosphataemia and symptomatic hypocalcaemia secondary to retention of phosphate administered through an antegrade continence enema is reported. Caution should be exercised with the use of phosphate enemas and prompt action taken to remedy retention. The use of glucose with insulin in the emergency management of acute hyperphosphataemia is discussed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1029243 | PMC |
| http://dx.doi.org/10.1136/adc.68.2.233 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A 47-Year-Old Man with Hyperphosphatemia Due to Chronic Renal Failure Treated with Lanthanum Carbonate Tablets Presenting Acutely with Partial Large Bowel Obstruction.
Am J Case Rep
November 2023
Department of Gastroenterology, General Hospital of Central Theater Command, Wuhan, Hubei, China (mainland).
BACKGROUND Hyperphosphatemia is a complication of chronic renal failure (CRF) due to reduction in the glomerular filtration rate. Lanthanum carbonate is a commonly used phosphate binder for patients with CRF and hyperphosphatemia, but has adverse effects if patients are not monitored. This report is of a 47-year-old man with hyperphosphatemia due to CRF treated with lanthanum carbonate tablets who presented acutely with partial large bowel obstruction.
View Article and Find Full Text PDFToxicity of phosphate enemas - an updated review.
Clin Toxicol (Phila)
June 2022
Pharmacology, Toxicology & Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Introduction: Enemas containing phosphate are widely prescribed and may cause important adverse effects. A systemic review published in 2007 reported the literature on the adverse effects of phosphate enemas from January 1957 to March 2007 and identified 12 deaths. These were thought due to electrolyte disturbances, heart failure and kidney injury.
View Article and Find Full Text PDFNovel intestinal dialysis interventions and microbiome modulation to control uremia.
Curr Opin Nephrol Hypertens
January 2022
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Purpose Of Review: In patients with chronic kidney disease (CKD), the gut plays a key role in the homeostasis of fluid and electrolyte balance and the production and disposal of uremic toxins. This review summarizes the current evidence on the gut-targeted interventions to control uremia, fluid overload, hyperkalemia and hyperphosphatemia in CKD.
Recent Findings: Studies have emerged that support the concept of intestinal dialysis, such as colonic perfusion with a Malone antegrade continence enema stoma or colonic irrigation with a rectal catheter, as a promising adjuvant approach to control uremia in CKD, although most findings are preliminary.
Sodium phosphate enemas do not worsen renal function among hospitalized patients with mild to moderate renal failure: a matched, case-control study.
QJM
December 2017
From the Department of Internal Medicine T (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Chaim Sheba Medical Center, Ramat Gan.
Background: Sodium phosphate enemas (SPEs) are widely used among hospitalized patients despite their potential to worsen renal failure.
Aim: We decided to assess the extent to which this side effect is clinically relevant.
Design: We conducted a matched case-control, retrospective study in a cohort of hospitalized patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!